首页> 外文期刊>Cholesterol >Modulators of Protein Kinase C Affect SR-BI-Dependent HDL Lipid Uptake in Transfected HepG2 Cells
【24h】

Modulators of Protein Kinase C Affect SR-BI-Dependent HDL Lipid Uptake in Transfected HepG2 Cells

机译:蛋白激酶C的调节剂影响转染的HepG2细胞中SR-BI依赖的HDL脂质摄取。

获取原文
       

摘要

SR-BI is a cell surface HDL receptor that mediates selective uptake of the lipid cargo of HDL, an important process in hepatocytes, driving reverse cholesterol transport from cells in the artery wall. To facilitate examination of factors that modulate SR-BI activity in hepatocytes, we have generated fluorescent protein-tagged versions of SR-BI that allow for facile monitoring of SR-BI protein levels and distribution in transfected cells. We show that deletion of the C-terminal cytosolic tail does not affect the distribution of SR-BI in HepG2 cells, nor is the C-terminal cytosolic tail required for SR-BI-mediated uptake of HDL lipids. We also demonstrate that the phorbol ester, PMA, increased, while protein kinase C inhibitors reduced SR-BI-mediated HDL lipid uptake in HepG2 cells. These data suggest that protein kinase C may modulate selective uptake of HDL lipids including cholesterol in hepatocytes, thereby influencing hepatic HDL cholesterol clearance and reverse cholesterol transport.
机译:SR-BI是一种细胞表面HDL受体,可介导HDL脂质货物的选择性摄取,HDL是肝细胞中的重要过程,可促使胆固醇从动脉壁细胞中逆向转运。为便于检查调节肝细胞中SR-BI活性的因素,我们生成了带有荧光蛋白标签的SR-BI版本,可轻松监测SR-BI蛋白水平和在转染细胞中的分布。我们表明,删除C末端胞质尾巴不会影响SR-BI在HepG2细胞中的分布,也不是SR-BI介导的HDL脂质摄取所需的C末端胞质尾巴。我们还证明了佛波酯PMA增加了,而蛋白激酶C抑制剂减少了HepG2细胞中SR-BI介导的HDL脂质摄取。这些数据表明蛋白激酶C可能调节选择性摄取HDL脂质(包括肝细胞中的胆固醇),从而影响肝脏HDL胆固醇清除率并逆转胆固醇转运。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号